Profound Hyperthermia After Postpartum Rectal Misoprostol Administration.
Gynuity Health Projects, New York, New York.
Jill
J
Durocher
Laura J
LJ
Frye
Beverly
B
Winikoff
D000284:Administration, Oral; D000285:Administration, Rectal; D005260:Female; D006801:Humans; D016595:Misoprostol; D010120:Oxytocics; D006473:Postpartum Hemorrhage; D049590:Postpartum Period
D010120:Oxytocics; D016595:Misoprostol
Kaiser J, Royer PA. Profound hyperthermia after postpartum rectal misoprostol administration. Obstet Gynecol 2016;127:1067–9.
Durocher J, Bynum J, Leon W, Barrera G, Winikoff B. High fever following postpartum administration of sublingual misoprostol. BJOG 2010;117:845–52.
Leon W, Durocher J, Barrera G, Pinto E, Winikoff B. Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make? BMC Pregnancy Childbirth 2012;12:65.
Alfirevic A, Durocher J, Elati A, León W, Dickens D, Rädisch S. Misoprostol-induced fever and genetic polymorphisms in drug transporters SLCO1B1 and ABCC4 in women of Latin American and European ancestry. Pharmacogenomics 2015;16:919–28.
World Health Organization. Recommendations for the prevention of postpartum haemorrhage. Geneva (Switzerland): WHO; 2012.
International Federation of Gynecology and Obstetrics. Prevention of post-partum haemorrhage with misoprostol. London (United Kingdom): FIGO; 2012.